|
|
Volumn 6, Issue 10 Suppl 2, 2004, Pages 24-30
|
|
Hypertension, renal disease, and drug considerations.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
ANGIOTENSIN RECEPTOR;
ANTIHYPERTENSIVE AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DIURETIC AGENT;
BLOOD PRESSURE;
CHRONIC DISEASE;
DOSE RESPONSE;
DRUG ANTAGONISM;
DRUG EFFECT;
HUMAN;
HYPERTENSION;
KIDNEY DISEASE;
METABOLISM;
REVIEW;
RISK FACTOR;
ADRENERGIC ALPHA-AGONISTS;
ADRENERGIC ALPHA-ANTAGONISTS;
ADRENERGIC BETA-ANTAGONISTS;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
BLOOD PRESSURE;
CALCIUM CHANNEL BLOCKERS;
CHRONIC DISEASE;
DIURETICS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
HYPERTENSION;
KIDNEY DISEASES;
RECEPTORS, ANGIOTENSIN;
RISK FACTORS;
MLCS;
MLOWN;
|
|
EID: 21644442311
PISSN: 15246175
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1524-6175.2004.03940.x Document Type: Review |
|
Times cited : (10)
|
|
References (41)
|
